Treatment of Cat Scratch Fever

Clinical Presentation and Diagnosis

A papule or pustule develops 3-30 days after a scratch or bite in patients with cat scratch disease, caused by Bartonella henselae 1
Regional lymphadenopathy occurs approximately 3 weeks after inoculation in patients with cat scratch disease 1
Lymphadenopathy generally resolves within 1-6 months, with suppuration in about 10% of cases in patients with cat scratch disease 1
Extranodal disease develops in ≤2% of cases in patients with cat scratch disease 1
PCR or Warthin-Starry silver stain of infected lymph node tissue can be used for diagnosis in difficult cases of cat scratch disease 1

Treatment Algorithm

The American College of Physicians recommends azithromycin as the first-line treatment for cat scratch disease, with a dosing protocol of 500 mg on day 1 followed by 250 mg for 4 additional days for patients >45 kg, or 10 mg/kg on day 1 and 5 mg/kg for 4 more days for patients <45 kg 1, 2
The Centers for Disease Control and Prevention recommends doxycycline 100 mg twice daily as an alternative treatment for cat scratch disease if azithromycin is contraindicated 3
The Centers for Disease Control and Prevention recommends erythromycin 500 mg four times daily as an alternative treatment for cat scratch disease if azithromycin is contraindicated 3

Prevention of Recurrence

Long-term suppression with erythromycin or doxycycline should be considered for patients with relapse or reinfection of cat scratch disease 4, 5
For pregnant women requiring long-term suppression of cat scratch disease, erythromycin should be used, as tetracyclines are contraindicated during pregnancy 4, 5

Evidence Quality and Treatment Efficacy

The recommendation for azithromycin is based on a placebo-controlled study showing more rapid reduction in lymph node size in patients receiving azithromycin compared to placebo 1
Treatment is recommended for immunocompromised patients with cat scratch disease 3
Treatment is recommended for cases with extranodal or disseminated disease of cat scratch disease 1

Prevention Measures

The Centers for Disease Control and Prevention recommends considering risks of cat ownership, particularly for severely immunosuppressed persons, to prevent Bartonella infection 4, 5
The Centers for Disease Control and Prevention recommends choosing a cat >1 year old in good health to prevent Bartonella infection 4, 5
The Centers for Disease Control and Prevention recommends avoiding rough play with cats and situations where scratches are likely to prevent Bartonella infection 4, 5
The Centers for Disease Control and Prevention recommends promptly washing any cat-associated wounds to prevent Bartonella infection 4, 5
The Centers for Disease Control and Prevention recommends implementing comprehensive flea control for cats to prevent Bartonella infection 4, 5
The Centers for Disease Control and Prevention recommends not allowing cats to lick open wounds to prevent Bartonella infection 4, 5

Special Considerations

The same treatment recommendations apply to children with cat scratch disease, with weight-based dosing for azithromycin 1, 2
Erythromycin is preferred for pregnant women with cat scratch disease, as tetracyclines should be avoided 4, 5
More aggressive and prolonged treatment is needed for HIV-infected patients with bacillary angiomatosis, particularly for cat scratch disease 3

Antibiotic Treatment for Cat Scratch Fever

Special Clinical Scenarios

The CDC recommends erythromycin or doxycycline for more than 3 months for HIV-infected patients with bacillary angiomatosis, peliosis hepatis, or CNS involvement 6
Doxycycline with or without rifampin is the treatment of choice for CNS bartonellosis and other severe infections, according to the CDC 6
Clarithromycin or azithromycin can be alternatives for patients unlikely to comply with more frequent dosing schedules, as suggested by the CDC 6
Penicillins and first-generation cephalosporins have no in vivo activity and should not be used for bartonellosis treatment, as stated by the CDC 6
Quinolones and TMP-SMX have variable in vitro activity and inconsistent clinical response, and are not recommended by the CDC 6

Treatment Duration and Monitoring

Extended therapy of more than 3 months is recommended for severe bartonellosis in immunocompromised patients, according to the CDC 6

Clinical Pitfalls

Serologic testing may not show detectable antibodies until 6 weeks after acute infection in immunocompetent patients, as reported by the CDC 6, 7
In advanced HIV infection, up to 25% of culture-positive patients may never develop antibodies, according to the CDC 6, 7
Bacillary angiomatosis in HIV/AIDS patients can be treated with erythromycin or doxycycline, as recommended by the CDC 6, 7

Diagnostic Approach for Cat Scratch Disease

Laboratory Testing and Diagnosis

Serologic testing is indicated when the clinical presentation is atypical, when extranodal disease is suspected, or when confirmation is needed for immunocompromised patients, as recommended by the Centers for Disease Control and Prevention 8, 9
In advanced HIV infection (CD4+ <100 cells/µL), up to 25% of culture-positive patients may never develop antibodies, highlighting the importance of alternative diagnostic methods in immunocompromised individuals 8
Warthin-Starry silver stain of biopsied lymph node tissue demonstrates characteristic bacilli and vascular proliferation, aiding in the diagnosis of atypical cases 8
Blood or tissue culture is the gold standard but not practical due to the fastidious nature of Bartonella, and culture is rarely performed in clinical practice and should not delay treatment 8
Immunocompromised patients (especially those with CD4+ counts <100 cells/µL) require more thorough evaluation as they are at risk for disseminated disease including bacillary angiomatosis, peliosis hepatis, and CNS involvement, as recommended by the Centers for Disease Control and Prevention 8, 9
Consider Bartonella in any HIV patient with unexplained fever and CD4+ <100 cells/µL 9
Evaluate for bacillary angiomatosis (cutaneous vascular lesions that can mimic Kaposi's sarcoma) in immunocompromised patients 8, 9
Do not test cats for Bartonella infection—this provides no benefit to diagnosis or management, as recommended by the American College of Physicians 10, 8

Special Considerations

Serology performed too early (<6 weeks) may yield false-negative results, and in immunocompromised patients, absence of antibodies does not exclude infection 8
Bacillary angiomatosis lesions can be clinically indistinguishable from Kaposi's sarcoma—biopsy may be necessary 8, 9

Antibiotic Treatment for Cat Scratch Disease

Treatment Recommendations

The Centers for Disease Control and Prevention recommends relapse prevention with long-term suppression using erythromycin or doxycycline until CD4+ >200 cells/µL for >6 months in immunocompromised patients 11, 12, 13
The Centers for Disease Control and Prevention recommends erythromycin as the only safe option for pregnant women, and to avoid tetracyclines (doxycycline) completely 11, 13, 14
The Centers for Disease Control and Prevention recommends fluoroquinolones be used with extreme caution in children and only if no alternatives exist 15, 16

Special Considerations

For HIV/AIDS patients, up to 25% may never develop antibodies despite active infection, and consideration of Bartonella is necessary in any HIV patient with unexplained fever and CD4+ <100 cells/µL 11, 12, 13
Gentamicin has shown 73% efficacy and rapid response within 48 hours for severe cases with hepatosplenic involvement, although the evidence quality is lower than azithromycin 11, 12, 13

Management of Cat Scratch Disease in Pregnant Women

Immediate Wound Management

Promptly washing any cat-associated wound with soap and water immediately after the scratch occurs is recommended by the Centers for Disease Control and Prevention, as this simple intervention is the most important initial step to reduce bacterial inoculation and prevent infection 17, 18, 19, 20, 21
The Centers for Disease Control and Prevention suggests that this intervention is crucial in preventing infection, as it reduces bacterial inoculation 18, 20

Risk Assessment for Pregnancy

The American College of Obstetricians and Gynecologists notes that pregnant women face unique considerations with Bartonella infection, though the evidence base is limited to HIV-infected pregnant women in the available guidelines, and pregnancy itself does not increase disease severity 17, 18, 19, 20, 21
The Centers for Disease Control and Prevention recommends that tetracyclines, such as doxycycline, are absolutely contraindicated during pregnancy due to their potential to cause harm to the fetus 17, 18, 19, 20, 21
The American Academy of Pediatrics states that fluoroquinolones should not be used during pregnancy due to their potential to cause harm to the fetus 19, 21
The American College of Obstetricians and Gynecologists suggests that erythromycin is safe for use during pregnancy, as it has a long history of safe use in pregnant women 17, 18, 19, 20, 21

Prevention Counseling for Future

The Centers for Disease Control and Prevention recommends avoiding rough play with cats and situations where scratches are likely, as well as not allowing cats to lick open wounds or cuts, to prevent future exposures 17, 18, 19, 20, 21
The American Veterinary Medical Association suggests implementing comprehensive flea control for household cats, as cat fleas are the vector of B. henselae among cats 22

When to Escalate Care

The Centers for Disease Control and Prevention notes that persistent fever without localizing signs in the context of recent cat exposure should prompt consideration of Bartonella bacteremia, and recommends close monitoring and potential treatment 22

Antibiotic Management of Disseminated Cat‑Scratch Disease in Breastfeeding Women

First‑Line Antibiotic Choice

Erythromycin 500 mg orally four times daily is the recommended first‑line therapy for Category III (disseminated/extranodal) cat‑scratch disease in breastfeeding patients; it is the only macrolide explicitly endorsed for use during pregnancy and lactation. 23
The treatment should be initiated immediately upon diagnosis. 23

Contraindicated or Non‑Recommended Antibiotics

Doxycycline is absolutely contraindicated in pregnant and breastfeeding women because of documented fetal and infant toxicity. 23
Fluoroquinolones should be avoided during pregnancy and lactation due to safety concerns. 23
Azithromycin, although first‑line for non‑pregnant patients, is not specifically endorsed for breastfeeding women; erythromycin remains the preferred macrolide. 23

Treatment Duration and Monitoring

For cutaneous or lymph‑node involvement, erythromycin should be continued for a minimum of 7–10 days. 24

Breastfeeding and Maternal Safety Considerations

Breastfeeding can be continued safely while the mother receives erythromycin, as the drug is considered compatible with lactation. 23
A recent cesarean delivery does not alter the choice of erythromycin, but the surgical wound should be monitored for infection. 23

Long‑Term Management and Relapse Prevention

If disease relapse occurs after the initial course, long‑term suppressive therapy with erythromycin may be considered. 23

All statements are derived from guideline‑based recommendations (Annals of Internal Medicine 1999; Clinical Infectious Diseases 2005). No explicit strength of evidence was provided in the source material.

Long‑Term Suppression Therapy for Relapse Prevention in Immunocompromised Patients with Cat‑Scratch Disease

Recommendation

For immunocompromised individuals with cat‑scratch disease, consider prolonged suppressive therapy using erythromycin or doxycycline to prevent disease relapse. This guidance applies to patients whose initial treatment course exceeds three months and who are at high risk for recurrence. The recommendation is based on expert consensus from the MMWR Recommendations and Reports (2002) 25.

Evidence strength: Expert opinion / guideline recommendation (no formal grading provided).